3Galanaud D, Chinot O, Nicoli F, et al. Use of Proton Magnetic Resonance Spectroscopy of the Brain to Differentiate Gliomatosis Cerebri from Low-Grade Glioma[J]. J Neurosurg, 2003,98 (2):269-276.
4Howe FA,Barton SJ,Cudlip SA, et al. Metabolic Profiles of Human Brain Tumors Using Quantitative in Vivo 1H Magnetic Resonance Spectroscopy[J]. Magn Reson Med, 2003,49 (2): 223-232.
5Opstad KS,Provencher SW,Bell BA,et al. Detection of Elevated Glutathione in Meningiomas by Quantitative in Vivo 1H MRS[J]. Magn Reson Med,2003,49(4) :632-637.
6Behar KL,Rothman DL,Spencer DD, et al. Analysis of Macromolecule Resonances in 1H NMR Spectra of Human Brain[J]. Magn Reson Med, 1994,32(3) :294-302.
7Isobe T, Matsumura A, Anno I, et al. Quantification of Cerebral Metabolites in Glioma Patients with Proton MR Spectroscopy Using T2 Relaxation Time Correction[J]. Magn Reson Imaging,2002,20(4) :343-349.
8Murphy PS,Rowland IJ,Viviers L,et al. Could Assessment of Glioma Methylene Lipid Resonance by in Vivo 1 H MRS be of Clinical Value[J]. Br J Radiol,2003,76(907) :459-463.
9Rijpkema M, Schuuring J, van der Meulen Y, et al. Characterization of Oligodendrogliomas Using Short Echo Time 1H MR Spectroscopic Imaging[J]. NMR Biomed,2003,16(1) :12-18.
10Tzika AA,Cheng LL,Goumnerova L, et al. Biochemical Characterization of Pediatric Brain Tumors by Using in Vivo and Ex Vivo Magnetic Resonance Spectroscopy[J]. J Neurosurg, 2002,96(6): 1023-1031.
二级参考文献1
1I.L. Simone,C. Tortorella,F. Federico. The contribution of 1H-magnetic resonance spectroscopy in defining the pathophysiology of multiple sclerosis[J] 1999,The Italian Journal of Neurological Sciences(2):S241～S245
